Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
120M
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
1.54M
-
Shares change
-
+1.54M
-
Total reported value, excl. options
-
$17.6M
-
Value change
-
+$17.6M
-
Number of buys
-
19
-
Price
-
$11.46
Significant Holders of IMMUNIC, INC. - Common Stock (IMUX) as of Q2 2019
21 filings reported holding IMUX - IMMUNIC, INC. - Common Stock as of Q2 2019.
IMMUNIC, INC. - Common Stock (IMUX) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.54M shares
of 120M outstanding shares and own 1.28% of the company stock.
Largest 10 shareholders include Omega Fund Management, LLC (1.37M shares), Independent Advisor Alliance (70.1K shares), MILLENNIUM MANAGEMENT LLC (29.8K shares), RENAISSANCE TECHNOLOGIES LLC (13.7K shares), BlackRock Inc. (12.6K shares), VANGUARD GROUP INC (11.5K shares), GEODE CAPITAL MANAGEMENT, LLC (10.6K shares), CREDIT AGRICOLE S A (9.7K shares), Tower Research Capital LLC (TRC) (2.91K shares), and BANK OF AMERICA CORP /DE/ (1.59K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.